SURROGEN

surrogen-logo

Surrogen is a biotech company delivering better models to understand human disease. It accelerates biomedical innovation by providing the drug and medical device industries with genetically-engineered, tailored large animal models as precise, reliable platforms to accelerate medical device and pharmaceutical development. The company's Patient Models help improve, enhance, and extend human life by providing large animal disease models that faithfully reproduce the disease indications seen in hum... an patients. Leveraging the critical assumption that the best substitutes are those closest to the original, Surrogen’s Patient Models bridge the gap between traditional animal models and clinical studies and serve as a platform to prove or disprove new ideas, exponentially speed up discovers, and significantly lower the total cost of getting new medical devices and drugs tested, approved and into use. Surrogen utilizes game-changing genetic technologies to develop large animal models with specific maladies and genetic conditions that provide a groundbreaking, preclinical opportunity for the world’s leading researchers, medical device, and pharmaceutical innovators to diminish lead times, lower research costs and reduce failure rates.

#SimilarOrganizations #Website #More

SURROGEN

Social Links:

Industry:
Biotechnology Genetics Health Care Medical Pharmaceutical

Founded:
2014-01-01

Address:
Eagan, Minnesota, United States

Country:
United States

Website Url:
http://www.recombinetics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]


Similar Organizations

asip-logo

ASIP

ASIP is a society of biomedical scientists who investigate mechanisms of disease.

bioorg314-logo

biOOrg3.14

biOOrg3.14 develops technologies and small molecules to fight human disease.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

neuclone-logo

NeuClone

NeuClone is a biotechnology company developing and commercializing high quality biosimilars.

regenevida-logo

Regenevida

Regenevida is a biotech company developing transplantable cells, tissues, and organs to save lives.

warren-center-for-neuroscience-drug-discovery-logo

Warren Center for Neuroscience Drug Discovery

Warren Center for Neuroscience Drug Discovery is a traditional academy in basic science to understand and treat human disease.

Official Site Inspections

http://www.recombinetics.com

  • Host name: 202.88.225.35.bc.googleusercontent.com
  • IP address: 35.225.88.202
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Surrogen"

Our Company - Recombinetics

Recombinetics’ ever-expanding pipeline of gene-edited animals, products, and preclinical services, position the company for rapid growth in biomedical and …See details»

Recombinetics - Crunchbase Company Profile & Funding

Recombinetics is a developer of gene editing technologies to improve human health through advanced disease models and regenerative medicine. Its gene-editing technologies …See details»

Our Team - Recombinetics

Recombinetics has strategically built our organization around two core markets— preclinical research & services, and a safe, abundant food supply. Our …See details»

Recombinetics - Wikipedia

Recombinetics is a St. Paul, Minnesota-based bio-engineering company. [1] The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the …See details»

Recombinetics - LinkedIn

Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing …See details»

Recombinetics 2025 Company Profile: Valuation, Funding

When was Recombinetics founded? Recombinetics was founded in 2008. Where is Recombinetics headquartered? Recombinetics is headquartered in Eagan, MN. What is the …See details»

Recombinetics Company Profile | Management and Employees List …

Recombinetics Profile and History. Founded in 2008, Recombinetics Inc. is a recognized global leader in the development, deployment, and commercialization of genetically engineered large …See details»

Recombinetics - Funding, Financials, Valuation & Investors

Aug 23, 2020 Recombinetics is funded by Grant Newlin. Recombinetics has a post-money valuation in the range of $100M to $500M as of Aug 22, 2018, according to PrivCo. Sign up for …See details»

Recombinetics - Company Profile - Tracxn

Feb 7, 2025 Recombinetics - Develops gene repair and gene-editing technology to create animal models. Raised a total funding of $65.5M over 12 rounds from 3 investors. Founded by Perry …See details»

Recombinetics Inc - Company Profile and News - Bloomberg …

Company profile page for Recombinetics Inc including stock price, company news, executives, board members, and contact informationSee details»

Company: Recombinetics

Mar 12, 2025 Recombinetics is gene-editing company, mainly focused on genetically engineering animals for agricultural and biomedical applications. The company's biomedical …See details»

Recombinetics | VentureRadar

Recombinetics develops and utilizes the best of gene editing technology to improve and lengthen human lives, and to improve and grow agriculture to help feed the world’s growing population …See details»

Recombinetics Company Information - Funding, Investors, and More

Recombinetics is a biotechnology company that uses gene editing for agriculture and medicine . Seedtable Score 76 Startups. 11. Funding Rounds. $67.4m. Money raised. About; Insights; …See details»

Recombinetics - Products, Competitors, Financials, Employees ...

Recombinetics focuses on animal gene editing and applied technologies in biomedical research, regenerative medicine, and animal agriculture. The company has a gene editing platform that …See details»

Recombinetics Company Overview, Contact Details & Competitors …

Gene-editing Technology Leader Recombinetics is a global leader in gene-editing technology, offering breakthrough solutions for regenerative medicine, disease research, and animal …See details»

Our Technology - Recombinetics

Recombinetics deploys gene editing in agriculture and aquaculture through its subsidiary Acceligen. Acceligen is the world leader in what is often referred to as “precision breeding”, …See details»

Recombinetics Company Profile - Craft

Recombinetics has 5 employees at their 1 location and $60.95 m in total funding,. See insights on Recombinetics including office locations, competitors, revenue, financials, executives, …See details»

Recombinetics Announces New Chief Executive Officer

Feb 11, 2019 PAUL, Minn.--(BUSINESS WIRE)--Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today named Mark Platt the organization’s …See details»

Recombinetics Chapter 11 - Recombinetics

On November 11, 2024, Recombinetics, Inc. (“Recombinetics” or “the Company”) announced a restructuring process intended to pave the way for a sale of substantially all of the Company’s …See details»

linkstock.net © 2022. All rights reserved